The shiny cylindrical tanks and slant-roofed control panels shoved against a wall in C3 Biotech’s laboratory have essentially been turned into a multimillion-dollar graveyard of high-grade stainless steel equipment. All of this state-of-the art gear was discarded during the company’s quest to discover a cheap way to convert agricultural waste like potato peels or sugar beet pulp into acrylic glass, a material widely used in manufacturing. Nigel Scrutton, a co-founder of C3 Biotech in Stockport, England, makes a point of showing off these expensive failures before explaining that the eureka…
Tag: Biotechnology and Bioengineering
China’s Rise in Drug Development Looms Over U.S.
For decades, an annual gathering of oncologists has featured drug trials that were run mainly at American and European hospitals. But at this year’s meeting, which is being held in Chicago this weekend, the signs are everywhere of China’s ascendance as a powerhouse in drug development — and of the threat that many believe it poses to American biotechnology. The clearest sign: In what appears to be a first, one of the conference’s five coveted headliners is a presentation of a clinical trial conducted only in China. That milestone at…
Chinese Spy Agency Rising to Challenge the C.I.A.
The Chinese spies wanted more. In meetings during the pandemic with Chinese technology contractors, they complained that surveillance cameras tracking foreign diplomats, military officers and intelligence operatives in Beijing’s embassy district fell short of their needs. The spies asked for an artificial intelligence program that would create instant dossiers on every person of interest in the area and analyze their behavior patterns. They proposed feeding the A.I. program information from databases and scores of cameras that would include car license plates, cellphone data, contacts and more. The A.I.-generated profiles would…
U.S. Cracks Down on Firms Said to Aid China’s Repression of Minorities
WASHINGTON — The Biden administration said on Thursday that it would put limits on doing business with a group of Chinese companies and institutions it says are involved in misusing biotechnology to surveil and repress Muslim minorities in China and advancing Beijing’s military programs. In announcing one set of the moves, Commerce Secretary Gina Raimondo said China was employing biotechnology and medical innovation “to pursue control over its people and its repression of members of ethnic and religious minority groups.” The administration said those efforts included the use of biometric…